High Heat Resistance

APTIV film has a RTI rating of 220°C (428°F) for m" />

Key Features

Dr Dietrich Müller GmbH

Key Features

High Heat Resistance

APTIV film has a RTI rating of 220°C (428°F) for mechanical use without
impact and 200°C (392°F) for electrical use for 25–125 micron films, and is
capable of withstanding lead-free solder processing temperatures of up to 300°C (572°F).

Excellent Wear Properties

Inherently lubricious, has a very smooth surface finish and low particulation. Limiting pressure velocity Lpv rating is 145 MPa.m/min (69,000 psi.ft/min) without the need for lubricants.

Low Moisture Absorption

Resists moisture that can adversely affect electrical, dimensional and mechanical properties of other materials.

Purity

Exceptionally low outgassing and extractables.

Outstanding Acoustic Properties

Excellent response, low distortion, high internal damping, low ringing.

Broad Chemical Resistance

Insoluble in all common solvents. Excellent resistance to acids,  oxidizing agents, hydrocarbons, salts and steam. Superior chemical resistance than many exotic metals.
Properties unaffected by exposure to steam at 200°C (392°F) after
2,000 hours.

Low Smoke and Toxic Gas Emission

Good flame resistance without the use of flame retardant additives and low toxicity of combustion gases. Inherently halogen-free in accordance with IEC 61249-2-21.

Environmentally Friendly

Lightweight, recyclable, halogenfree, withstands lead-free soldering process temperatures and is RoHS compliant.

High Strength and Toughness

Highest stiffness and resistance to cyclic fatigue of any thermoplastic. Strength is maintained well over the glass transition temperature (Tg). Excellent tear strength, puncture resistance and acoustic fatigue properties.

Electrical Stability

Very stable dielectric properties over a wide range of temperatures, frequencies and humidities.

FDA Food Contact Certified

APTIV film grades 1000, 1100, 1300, 2000 and 2100 may be safely used
for repeated food contact. They comply with the compositional requirements of FDA 21 CFR 177.2415, Commission Directive 1935/2004/EC and 2002/72/EC and the amendments up to 2005/79/EC.

Share this post